Will retatrutide replace Mounjaro on the NHS
AOD-9604 the HGH fragment 176-191, studied specifically for lipolytic effects on adipose tissue
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial
Our experts curated this collection to help support a GLP-1 users nutritional needs
PlexusDx's Precision Peptide Genetic Test analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to show how your system regulates appetite and energy expenditure
Initial study results show that people lose a larger percentage of weight as much as 30% of their body weight when they take retatrutide compared with placebo